natgillin/translations-raw huggingface dataset:
Doseringsskema for vedligeholdelsesdosis:
Dose scheme for the maintenance dose:
Meloxicam findes overvejende i plasma.
Meloxicam is predominantly found in plasma.
I tilfælde af overdosering kan bivirkninger, som angivet i afsnit 4.6, optræde alvorligere og hyppigere.
In case of overdose, adverse reactions, as listed in section 4.6, are expected to be more severe and more frequent.
Kvæg, svin og heste
Cattle, pigs and horses
Enhver oral opfølgningsbehandling med meloxicam eller et andet NSAID-præparat må ikke anvendes til katte, da passende dosering for en sådan behandling ikke er fastlagt.
Any oral follow-up therapy using meloxicam or other NSAIDs should not be administered in cats, as appropriate dosage regimens for such follow-up treatments have not been established.
Postoperative smerter og inflammation efter kirurgiske indgreb: I tilfælde hvor supplerende smertelindring er nødvendig, bør multimodal smertebehandling overvejes.
Post-operative pain and inflammation following surgical procedures: In case additional pain relief is required, multimodal pain therapy should be considered.
Maksimal plasmakoncentration opnås efter cirka 2-3 timer.
Maximal plasma concentrations are obtained after approximately 2-3 hours.
En ml indeholder:
One ml contains:
Ved behandling af diarré hos kvæg bør præparatet ikke gives til dyr, som er mindre end en uge gamle.
For the treatment of diarrhoea in cattle, do not use in animals of less than one week of age.
Behandling af kalve med Inflacam 20 minutter før afhorning reducerer postoperativ smerte.
Treatment of calves with Inflacam 20 minutes before dehorning reduces post-operative pain.
Distributionsvolumen er 0,3 l/kg hos hunde og 0,09 l/kg hos katte.
The volume of distribution is 0.3 l/kg in dogs and 0.09 l/kg in cats.
Renset vand
Purified water
Behandling af smågrise med Inflacam inden kastration reducerer posteropative smerter.
Treatment of piglets with Inflacam before castration reduces post-operative pain.
I mindre udstrækning hæmmes også collagen-induceret trombocyt-aggregation.
To a minor extent it also inhibits collagen-induced thrombocyte aggregation.
Kvalitativt er metabolismen ens hos rotter, smågrise, mennesker, kvæg og svin (herunder mini svin), men kvantitativt er der forskelle.
The metabolism is qualitatively similar in rats, humans, cattle and pigs (including mini-pigs), although quantitatively there are differences.
Hovedmetabolitterne, som blev fundet i alle species var 5-hydroxyog 5- carboxymetabolitter samt oxalyl-metabolitten.
The major metabolites found in all species were the 5-hydroxyand 5-carboxy- metabolites and the oxalyl- metabolite.
Dette lægemiddel er til hunde og må ikke bruges til katte da det ikke er egnet til brug hos denne dyreart.
This product for dogs should not be used in cats as it is not suitable for use in this species.
Hvis lægemidlet opblandes i foderet, bør det tilsættes en lille mængde foder, som gives lige inden fodring.
In case the product is mixed with food, it should be added to a small quantity of food, prior to feeding.
Kroniske lidelser i bevægeapparatet: Reaktion ved langtidsbehandling bør overvåges regelmæssigt af dyrlægen.
Chronic musculoskeletal disorders: Response to long-term therapy should be monitored at regular intervals by a veterinary surgeon.
En klinisk reaktion ses normalt inden for 7 dage.
A clinical response is normally seen within 7 days.
For at opnå den bedst mulige posteropative smertelindrende effekt, bør Inflacam administreres 30 minutter før et kirurgisk indgreb.
To obtain the best possible relieving effect post-surgery Inflacam should be administered 30 minutes before surgical intervention.
Veterinærlægemidlets sikkerhed under drægtighed og laktation er ikke fastlagt.
The safety of the veterinary medicinal product has not been established during pregnancy and lactation.
Der bør udvises særlig omhyggelighed i forbindelse med doseringsnøjagtigheden.
Particular care should be taken with regard to the accuracy of dosing.
Sprøjten passer til flasken og er forsynet med en 2 ml skala.
The syringe fits onto the bottle and has a 2 ml scale.
Der ses relativt lave koncentrationer i muskler og fedt.
Comparatively low concentrations are detectable in skeletal muscle and fat.
Alle hovedmetabolitter har vist sig at være farmakologisk inaktive.
All major metabolites have been shown to be pharmacologically inactive.
Kvalitativt er metabolismen ens hos rotter, smågrise, mennesker, kvæg og svin, men kvantitativt er der forskelle.
The metabolism is qualitatively similar in rats, mini-pigs, humans, cattle and pigs, although quantitatively there are differences.
Akkumulationsfaktoren er 1,08, hvilket indikerer, at meloxicam ikke akkumuleres ved daglig indgift.
The accumulation factor of 1.08 suggests that meloxicam does not accumulate when administered daily.
Til anvendelse ved akut respiratorisk infektion i kombination med passende antibiotika-behandling med henblik på at reducere kliniske symptomer hos kvæg.
For use in acute respiratory infection with appropriate antibiotic therapy to reduce clinical signs in cattle.
Drægtighed and lactation
Pregnancy and lactation:
Til anvendelse ved diarré i kombination med oral tilførsel af vand med henblik på at reducere kliniske symptomer hos kalve, der er mere end en uge gamle, og hos ikke-lakterende ungkvæg.
For use in diarrhoea in combination with oral re-hydration therapy to reduce clinical signs in calves of over one week of age and young, non-lactating cattle.
Hunde: i.v eller s.c Katte: s.c
Dogs: IV or SC. Cats: SC.
Antal tyggetabletter mg/kg
Number of chewable tablets mg/kg
Papir folie poser (papir/PE/alu/PE) indeholdende 1,5 g granulat pr pose i en papkasse.
Paper foil sachets (paper/PE/alu/PE) containing 1.5 g granules per sachet in a cardboard box.
I tilfælde af utilstrækkelig smertelindring ved behandling af kolik hos hest bør diagnosen revurderes omhyggeligt, da der kan være behov for kirurgisk indgreb.
In case of inadequate relief of pain when used in the treatment of equine colic, careful re-evaluation of the diagnosis should be made as this could indicate the need for surgical intervention.
Bør ikke anvendes til grise, som er under 2 dage gamle.
Do not use in pigs less than 2 days old.
Lokomotoriske forstyrrelser:
Locomotor disorders:
20 tabletter 100 tabletter
20 tablets 100 tablets
Den perorale opfølgningsdosis må indgives én gang dagligt (24 timers interval) i op til 4 dage.
The oral follow-up dose may be administered once daily (at 24-hour intervals) for up to 4 days.
Præcisionen af sprøjten er ikke egnet til behandling af katte under 1 kg. Omrystes godt før brug.
The precision of the syringe is not suitable for the treatment of cats below 1 kg.
In vitro og in vivo studier har vist, at meloxicam i højere grad hæmmer cyclooxygenase-2 (COX-2) end cyclooxygenase-1 (COX-1).
In vitro and in vivo studies demonstrated that meloxicam inhibits cyclooxygenase-2 (COX-2) to a greater extent than cyclooxygenase-1 (COX-1).
Til anvendelse ved ikke-smitsomme lokomotoriske forstyrrelser med henblik på at reducere halthed og inflammation.
For use in non-infectious locomotor disorders to reduce the symptoms of lameness and inflammation.
Som for andre undersøgte dyrearter, sker den primære biotransformation af meloxicam i katte via oxidation.
As for other species investigated, the main pathway of meloxicam biotransformation in cat is oxidation.
15 ml HDPE flaske med børnesikret lukning eller 42, 100 eller 200 ml polyethylenterephthalat (PET) flaske med børnesikret lukning, og to polypropylen doseringssprøjte: en for små hunde (0-20 kg) og en til større hunde (0-60 kg).
15 ml HDPE bottle with a tamper resistant child proof closure or 42, 100 or 200 ml polyethylene terephthalate (PET) bottle with a tamper resistant child proof closure and two polypropylene measuring syringes: one for small dogs (up to 20 kg) and one for bigger dogs (up to 60 kg).
21 % af den genfundne dosis elimineres i urin (2 % som uændret meloxicam, 19 % som metabolitter) og 79 % i fæces (49 % som uændret meloxicam, 30 % som metabolitter).
21% of the recovered dose is eliminated in urine (2% as unchanged meloxicam, 19% as metabolites) and 79% in the faeces (49% as unchanged meloxicam, 30% as metabolites).
Dato for første markedsføringstilladelse: 09/12/2011 Dato for seneste fornyelse af markedsføringstilladelse: 09/11/2016
Date of first authorisation: 09/12/2011 Date of latest renewal: 09/11/2016
TEKSTEN "KUN TIL DYR" SAMT BETINGELSER ELLER BEGRÆNSNINGER FOR UDLEVERING OG BRUG, om nødvendigt
THE WORDS “FOR ANIMAL TREATMENT ONLY” AND CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE, IF APPLICABLE
Opbevaringstid efter opblanding i müsli foder: anvendes straks.
Shelf life after incorporation into muesli feed: use immediately.
Kvæg (kalve og ungkvæg) og svin.
Cattle (calves and young cattle) and pigs
Reduktion af postoperative smerter:
Reduction of post-operative pain:
Se afsnittet 'Kontraindikationer'.
See section "Contraindications".
Hyppigheden af bivirkninger er defineret som: - Meget almindelige (flere end 1 ud af 10 behandlede dyr, der viser bivirkninger) - Almindelige (flere end 1, men færre end 10 dyr ud af 100 behandlede dyr) - Ikke almindelige (flere end 1, men færre end 10 dyr ud af 1.000 behandlede dyr) - Sjældne (flere end 1, men færre end 10 dyr ud af 10.000 behandlede dyr) - Meget sjældne (færre end 1 dyr ud af 10.000 behandlede dyr, herunder isolerede rapporter).
The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 animals treated displaying adverse reactions) - common (more than 1 but less than 10 animals in 100 animals treated) - uncommon (more than 1 but less than 10 animals in 1,000 animals treated) - rare (more than 1 but less than 10 animals in 10,000 animals treated) - very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
Behandlingen bør afbrydes senest efter 10 dage, hvis der ikke ses klinisk bedring.
Treatment should be discontinued after 10 days at the latest if no clinical improvement is apparent.
Ved initiering af behandling gives der på den første dag en dobbelt så stor dosis som vedligeholdelsesdosis.
For initiation of the therapy on the first day, twice the maintenance dosage will be required.
Behandlingen bør afbrydes senest efter 14 dage, hvis der ikke ses klinisk bedring.
Treatment should be discontinued after 14 days at the latest if no clinical improvement is apparent.
Hvis De bemærker alvorlige bivirkninger eller andre bivirkninger, som ikke er omtalt i denne indlægs seddel, bedes De kontakte Deres dyrlæge.
If you notice any serious effects or other effects not mentioned in this leaflet, please inform your veterinary surgeon.
Det farmakologisk aktive stof
Pharmacologically active substance
Til supplerende behandling af puerperal sepsis og toksikæmi (mastitis-metritis-agalaktisk syndrom) med passende antibiotika-behandling.
For adjunctive therapy in the treatment of puerperal septicaemia and toxaemia (mastitis-metritisagalactia syndrome) with appropriate antibiotic therapy.
Pakkens størrelser
PACKAGE SIZE
Til supplerende behandling af akut mastitis i kombination med antibiotika-behandling.
For adjunctive therapy in the treatment of acute mastitis, in combination with antibiotic therapy.
Ved længerevarende behandling kan Inflacam dosis justeres til den individuelt laveste effektive dosis så snart klinisk respons er observeret (efter ≥ 4 dage), for at imødekomme at graden af smerte og inflammation ved kroniske lidelser i bevægeapparatet kan variere over tid.
For longer term treatment, once clinical response has been observed (after ≥ 4 days), the dose of Inflacam can be adjusted to the lowest effective individual dose reflecting that the degree of pain and inflammation associated with chronic musculo-skeletal disorders may vary over time.
En hest, der vejer 500 kg vil få 20 ml Inflacam, og en hest, der vejer 600 kg vil få 24 ml Inflacam.
For example, a horse weighing 400 kg will receive 16 ml of Inflacam, a horse weighing 500 kg will receive 20 ml of Inflacam, and a horse weighing 600 kg will receive 24 ml of Inflacam.
Når præparatet anvendes i overensstemmelse med den anbefalede daglige dosering, nås steady-state koncentrationer af meloxicam på anden dagen efter behandlingens påbegyndelse.
When the product is used according to the recommended dosage regime, steady state concentrations of meloxicam in plasma are reached on the second day of treatment.
Elimination Meloxicam elimineres med en terminal halveringstid på 7,7 timer.
Elimination Meloxicam is eliminated with a terminal half-life of 7.7 hours.
Hos svin, efter intramuskulær administration, er den gennemsnitlige halveringstid ca. 2,5 time.
In pigs, after intramuscular administration the mean plasma elimination half-life is approximately 2.5 hours.
Påvisning af metabolitter fra den uomdannede substans i urin og fæces, men ikke i plasma, indikerer hurtig udskillelse af metabolitterne.
The detection of metabolites from the parent compound in urine and faeces, but not in plasma is indicative for their rapid excretion.
Hver tyggetablet kan halveres således at dosering bliver korrekt svarende til dyrets individuelle legemsvægt.
Each chewable tablet can be halved for accurate dosing according to the individual body weight of the animal.
Talkum
Talc
En klinisk reaktion ses normalt inden for 3-4 dage.
A clinical response is normally seen within 3-4 days.
Hvis dyret faster når dosis gives, opnås den maksimale plasmakoncentration efter ca. 3 timer.
If the animal is fasted when dosed, the maximal plasma concentrations are obtained after approximately 3 hours.
Hver pose indeholder en dosis til en hest på mellem 500 og 600 kg, og dosis må ikke opdeles i mindre doser.
Each sachet contains one dose for a horse weighing between 500 and 600 kg and the dose must not be divided into smaller doses.
TEKSTEN "KUN TIL DYR" SAMT BETINGELSER ELLER BEGRÆNSNINGER FOR UDLEVERING OG BRUG, OM NØDVENDIGT
THE WORDS “FOR ANIMAL TREATMENT ONLY” AND CONDITIONS OF RESTRICTIONS REGARDING SUPPLY AND USE, IF APPLICABLE
Efter intravenøs injektion til heste elimineres meloxicam med en terminal halveringstid på 8,5 time.
In horses, after intravenous injection meloxicam is eliminated with a terminal half-life of 8.5 hours.
15, 42, 100 eller 200 ml flaske med to doseringssprøjtes.
15, 42, 100 or 200 ml bottle with two measuring syringes.
De fem hovedmetabolitter har alle vist sig at være farmakologisk inaktive.
Five major metabolites were detected all having been shown to be pharmacologically inactive.
Papæske (100s)
Cardboard box (100s)
Meloxicam elimineres med halveringstider på 26 og 17,5 timer efter subkutan injektion hos henholdsvis ungkvæg og lakterende køer.
Meloxicam is eliminated with a half-life of 26 hours and 17.5 hours after subcutaneous injection in young cattle and lactating cows, respectively.
Fordelingsvoluminet er 0,12 l/kg.
The volume of distribution is 0.12 l/kg.
Reduktion af postoperative smerter (over en periode på 24 timer): Enkelt intravenøs eller subkutan injektion før indgrebet, for eksempel ved indledning af anæstesi.
Reduction of post-operative pain (over a period of 24 hours): single intravenous or subcutaneous injection before surgery, for example, at the time of induction of anaesthesia.
For Inflacam 20 mg/ml injektionsvæske, opløsning til kvæg, svin og heste og Inflacam 5 mg/ml injektionsvæske, opløsning til hunde og katte og Inflacam 5 mg/ml injektionsvæske, opløsning til kvæg og svin kun:
For Inflacam 20 mg/ml solution for injection for cattle, pigs and horses and Inflacam 5 mg/ml solution for injection for cats and dogs and Inflacam 5 mg/ml solution for injection for cattle and pigs only:
Ca. 50 % af den indgivne dosis elimineres via urinen og resten med fæces.
Approximately 50 % of the administered dose is eliminated via urine and the remainder via faeces.
Bør ikke anvendes til hunde under 6 uger eller med mindre end 4 kg legemsvægt.
Do not use in dogs less than 6 weeks of age or less than 4 kg body weight.
Hos svin indeholder galde og urin kun spor af moderstoffet.
In pigs, bile and urine contain only traces of the parent compound.
Hver tyggetablet indeholder enten 1 mg eller 2,5 mg meloxicam, som svarer til den daglige vedligeholdelsesdosis for en hund med henholdsvis 10 kg eller 25 kg legemsvægt.
Each chewable tablet contains either 1 mg or 2.5 mg meloxicam, which corresponds to the daily maintenance dose for a 10 kg body weight dog, or a 25 kg body weight dog respectively.
Må ikke anvendes til heste, hvis mælk er bestemt til menneskeføde.
Not authorised for use in horses producing milk for human consumption.
I tilfælde af overdosering kan bivirkninger, som angivet i afsnit 'Bivirkninger', optræde alvorligere og hyppigere.
In case of overdose, adverse reactions, as listed in section "Adverse reactions", are expected to be more severe and more frequent.
For at opnå smertelindring under operation er samtidig medicinering med et passende anæstetikum/sedativum nødvendig.
To obtain pain relief during surgery co-medication with an appropriate anaesthetic/sedative is needed.
5 DYREARTER
Animal species
Kvæg:
Cattle:
Reduktion af postoperative smerter efter ovariehysterektomi og mindre omfattende bløddelskirurgi: Enkelt subkutan injektion af en dosis før indgrebet, for eksempel ved indledning af anæstesi.
Reduction of post-operative pain after ovariohysterectomy and minor soft tissue surgery: single subcutaneous injection before surgery, for example, at the time of induction of anaesthesia.
Længden af den behandlingsfri periode bør dog fastlægges under hensyntagen til de farmakokinetiske egenskaber af tidligere anvendte veterinærlægemidler.
The treatment-free period, however, should take into account the pharmacokinetic properties of the veterinary products used previously.
Ca. 75 % af den indgivne dosis elimineres via fæces og den resterende del med urinen.
Approximately 75 % of the administered dose is eliminated via faeces and the remainder via urine.
Tilbageholdelsestid:
Withdrawal period:
En glat lysegul suspension.
A smooth light yellow suspension.
- Ethanol (96%) - Poloxamer 188 - Macrogol 400 - Glycin - Dinatriumedetat - Natriumhydroxid - Saltsyre - Meglumin - Vand til injektionsvæsker
- Ethanol (96%) - Poloxamer 188 - Macrogol 400 - Glycine - Disodium edetate - Sodium hydroxide - Hydrochloric acid, concentrated - Meglumine - Water for injections
Sprøjten passer til flasken og er forsynet med en kg-legemsvægt skala, som svarer til vedligeholdelsesdosis (d.v.s. 0,1 mg meloxicam/kg legemsvægt).
The syringe fits onto the bottle and has a kg-body weight scale which corresponds to the maintenance dose (i.e. 0.1 mg meloxicam/kg body weight).
Der er linearitet mellem den indgivne dosis og de observerede plasmakoncentrationer efter indgift af terapeutiske doser.
There is a linear relationship between the dose administered and plasma concentration observed in the therapeutic dose range.
Bleggule granulat.
Pale yellow granules.
For at opnå tilstrækkelig smertelindring under kirurgi er yderligere medicinering med passende analgetikum nødvendig.
To obtain adequate pain relief during surgery co-medication with an appropriate analgesic is needed.
- Ethanol (96%) - Poloxamer 188 - Macrogol 400 - Glycin - Natriumhydroxid - Saltsyre - Meglumin - Vand til injektionsvæsker
- Ethanol (96%) - Poloxamer 188 - Macrogol 400 - Glycine - Sodium hydroxide - Hydrochloric acid, concentrated - Meglumine - Water for injections.
Længden af den behandlingsfri periode bør dog fastlægges under hensyntagen til de farmakologiske egenskaber af tidligere anvendte præparater.
The treatment-free period, however, should take into account the pharmacological properties of the products used previously.
Efter subkutan administration er meloxicam fuldstændigt biotilgængeligt, og maksimale gennemsnitlige plasmakoncentrationer på 0,73 g/ml hos hunde og 1,1 g/ml hos katte opnåedes henholdsvis ca. 2,5 og 1,5 time efter administration.
Following subcutaneous administration, meloxicam is completely bioavailable and maximal mean plasma concentrations of 0.73 µg/ml in dogs and 1.1 μg/ml in cats were reached approximately 2.5 hours and 1.5 hours post administration, respectively.
Papæske (20s)
Cardboard box (20s)
Silica, kolloid vandfri Vand, renset
Silica, colloidal anhydrous Water, purified
Hver pose indeholder:
Each chewable tablet contains:
Samtidig administration af potentielt nefrotoksiske veterinærlægemidlerbør undgås.
Concurrent administration of potential nephrotoxic veterinary medicinal products should be avoided.
MINDSTEKRAV TIL OPLYSNINGER PÅ BLISTERKORT ELLER BLISTERSTRIPS MINDSTEKRAV TIL OPLYSNINGER PÅ BLISTERKORT ELLER BLISTERSTRIPS
MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS
Kvæg: Kan anvendes under drægtighed.
Cattle: Can be used during pregnancy.
I meget sjældne tilfælde er der set appetitløshed, lethargi, abdominale smerter, og kolitis.
In very rare cases loss of appetite, lethargy, abdominal pain and colitis have been reported.
Må ikke anvendes til dyr under 6 uger eller katte på mindre end 2 kg.
Do not use in animals less than 6 weeks of age nor in cats of less than 2 kg.
Skal indgives oralt, enten opblandet i foder eller direkte i munden.
To be administered orally either mixed with food or directly into the mouth.
Samtidig administration af potentielt nefrotoksiske lægemidler bør undgås.
Concurrent administration of potential nephrotoxic drugs should be avoided.
Sørg for at dosere nøjagtigt, at bruge passende injektionssprøjte samt at vurdere legemsvægten.
Take care of accurate dosing, use of appropriate dosing devise and estimation of body weight.
Der foreligger ikke data vedrørende heste, og anvendelse til heste under drægtighed og laktation kan derfor ikke anbefales.
Therefore the use in horses is not recommended during pregnancy and lactation.
Fordelingsvoluminet er 0,3 l/kg.
The volume of distribution is 0.3 l/kg.
Oral suspension indgives i en dosis på 0,6 mg/kg legemsvægt, én gang dagligt, i op til 14 dage.
Oral suspension to be administered at a dosage of 0.6 mg/kg body weight, once daily, up to 14 days.
Kontraindikationer
CONTRAINDICATIONS
Må ikke anvendes til lakterende dyr, hvis mælk er bestemt til menneskeføde.
Not authorised for use in lactating animals producing milk for human consumption.
I meget sjældne tilfælde kan anafylaktiske reaktioner forekomme og bør behandles symptomatisk.
In very rare cases, anaphylactoid reactions may occur and should be treated symptomatically.
Overdosis (symptomer, nødforanstaltninger, modgift) I tilfælde af overdosering bør symptomatisk behandling initieres.
Overdose (symptoms, emergency procedures, antidotes): In the case of overdose, symptomatic treatment should be initiated.
Meloxicam absorberes fuldstændigt efter peroral administration, og den maksimale plasmakoncentration opnås efter ca. 4,5 time.
Meloxicam is completely absorbed following oral administration and maximal plasma concentrations are obtained after approximately 4.5 hours.
Meloxicam absorberes fuldstændigt efter peroral administration, og den maksimale plasmakoncentration opnås efter ca. 7,5 time.
Meloxicam is completely absorbed following oral administration and maximal plasma concentrations are obtained after approximately 7.5 hours.
Dinatriumhydrogenphosphat, dodecahydrat Natriumbenzoat
Disodium hydrogen-phosphate dodecahydrate Sodium benzoate
TEKSTEN "OPBEVARES UTILGÆNGELIGT FOR BØRN"
THE WORDS “KEEP OUT OF THE SIGHT AND REACH OF CHILDREN”
Må ikke bruges i tilfælde af overfølsomhed over for det aktive stof, eller et eller flere af hjælpestofferne.
Do not use in case of hypersensitivity to the active substance or to any of the excipients.
Skal indgives enten tilsat en lille mængde foder, som gives lige inden fodring, eller direkte i munden.
To be administered either mixed with a small quantity of food, prior to feeding, or directly into the mouth.
Heste: Se afsnittet 'Kontraindikationer'
Horses: See section "Contraindications".
Natriumdihydrogenphosphat, monohydrat Simethicon emulsion Honningaroma
Sodium dihydrogen phosphate monohydrate Simethicone emulsion Honey flavour